The strategic decision to end further internal development of the ex-Novartis asset, dubbed naporafenib, will allow Erasca to ...

By Daniella Parra Jeito Capital said it is leading a €132 million oversubscribed Series B funding round in Azafaros, a ...

Bluebird bio shareholders have dragged their feet in tendering shares as part of the company’s sale process, prompting buyers ...

Viking Therapeutics has a promising pipeline candidate in the fast-growing therapeutic area of weight loss. Madrigal ...

President Trump announced a plan to reduce prescription drug prices by implementing a most-favored-nation policy with the ...

The company had also said last month that Paul Stoffels, a pharma legend who took on the CEO role in 2022 in a bid to ...

To­day on Post Hoc Live, Drew Arm­strong is joined by Nick Ship­ley, the for­mer top lob­by­ist for the biotech in­dus­try, ...

The University of California won a big battle in the ongoing patent war over a gene-editing system central to a 2020 Nobel ...

San Diego is rapidly emerging as a major part of California’s life sciences industry. By the end of 2025, the completion of ...

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at ...

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at ...